Earlier this year, Eli Lilly chief executive officer John Lechleiter lamented that US colleges were failing to churn out sufficient numbers of students with bachelor's degrees in science, technology, engineering and math to meet the high-tech needs of the future. This development, he argued in a series of speeches and newspaper columns, is contributing to a lack of needed innovation and, subsequently, placing the long-term health of the U.S. economy at risk.
To read the full, original article click on this link: NJ Spotlight | Cooperation Is the Key for NJ's Universities and Biotechs
Author:
